A study by researchers from the University of Granada, the University of Wisconsin-Madison and Columbia University has provided new data on the Q10 coenzyme (CoQ10), a molecule which is synthesized within the cells of the organism itself and which has essential functions for cellular metabolism. This study opens the door for the development of tools to modulate the synthesis of CoQ10 in human cells according to their metabolic needs. This will be particularly important for the treatment of diseases caused by primary and secondary deficiencies in CoQ10. The study is published in the journal PNAS.
Its role in the production of energy required by the cell and its antioxidant capacity are among the best known functions of this coenzyme. Human cases have been described in which the deficiency in CoQ10 can be attributed to defects in the biosynthetic pathway, which causes a syndrome with a very heterogeneous clinical picture.
CoQ10 deficiency is a rare mitochondrial disease which affects mostly children. The details of this biosynthetic pathway are not known in their totality, since there are steps whose catalysing enzymes remain unknown, or proteins in the pathway whose specific function is either unknown or has not yet been fully demonstrated.
One of those proteins is Coq9, which the researchers demonstrated in 2013 is an essential protein in the biosynthesis of CoQ, and which specifically regulates the Coq7 protein, an enzyme with a hydroxylase activity that catalyses one of the intermediate steps for the synthesis of CoQ10.
The team state that this research conclusively proves that protein CoQ9 regulates enzyme CoQ7.
The team summise that through the crystallization of the human protein and experiments conducted on mice, the study proves that Coq9 has a lipid-binding structure, which would give it the capacity to provide enzyme Coq7 with the intermediary metabolite that it uses as a substrate in the reaction it catalyses.
The results of the study suggest, besides, that the biosynthetic machinery of CoQ10 is organized as a multiprotein complex in mammals, with the purpose of increasing the efficiency of its synthesis and enable its regulation.
Source: University of Granada
Michelle is a health industry veteran who taught and worked in the field before training as a science journalist.
Featured by numerous prestigious brands and publishers, she specializes in clinical trial innovation--expertise she gained while working in multiple positions within the private sector, the NHS, and Oxford University.